Can Clostridioides difficile be detected in a patient who has only the upper half of the body and a colostomy?

Can C. difficile Be Detected in a Patient with a Colostomy?

Yes, C. difficile can absolutely be detected in patients with colostomies, and testing should be performed when clinically indicated. The presence of a colostomy does not preclude C. difficile infection or its detection, though the anatomical changes require specific considerations for specimen collection and interpretation.

Key Diagnostic Considerations

Specimen Collection in Ostomy Patients

The 2019 WSES guidelines specifically address this scenario and provide clear guidance 1:

• For patients unable to produce stool specimens (including those with severe CDI complicated by ileus or altered anatomy), perirectal swabs provide an acceptable alternative with excellent test characteristics 1
• A prospective study demonstrated perirectal swab sensitivity of 95.7%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 99.1% when tested by PCR 1

For colostomy patients specifically: Collect effluent directly from the ostomy appliance when diarrheal output is present (≥3 unformed stools in 24 hours) 1. If output is minimal or the patient has ileus, perirectal swabs from the remaining rectal stump (if present) can be utilized 1.

When to Test

Testing should only be performed in symptomatic patients with:

• Increased ostomy output (analogous to diarrhea)
• Clinical signs: fever, abdominal pain, leukocytosis
• Relevant risk factors: recent antibiotic use, hospitalization, advanced age 1

Critical pitfall: Do not test formed stool or routine ostomy output, as this leads to false positives from asymptomatic colonization and unnecessary treatment 1.

Recommended Testing Algorithm

Based on the 2019 WSES guidelines 1:

1. First-line approach: Two-step algorithm

   • Screen with GDH (glutamate dehydrogenase) EIA
   • If GDH positive, confirm with toxin A/B EIA
   • This balances sensitivity and specificity while avoiding overdiagnosis

2. Alternative approach: NAAT (nucleic acid amplification test)

   • Use in patients with high clinical suspicion for CDI
   • Caution: NAAT cannot distinguish colonization from active infection, potentially leading to overdiagnosis 1
   • Best reserved for high-suspicion cases or as part of two-step algorithm starting with toxin-EIA 1

Special Considerations for Ostomy Patients

Small Bowel Involvement

Important clinical pearl: C. difficile can cause small bowel disease in patients with ileostomies or altered anatomy 2, 3:

• High-output ileostomy may be caused by enteric C. difficile infection 2
• C. difficile has been recognized in ~10% of symptomatic ileal pouch patients at tertiary centers 3
• The management algorithm for high-output ileostomy should include exclusion of C. difficile 2

Anatomical Context Matters

For a patient with "only half a body" (hemicorporectomy) and colostomy:

• The remaining colon proximal to the colostomy can still harbor C. difficile
• Test ostomy effluent when symptomatic
• Consider that small bowel involvement is possible if the patient has had extensive colonic resection 2, 4

Diagnostic Limitations

When standard testing fails but suspicion remains high 5:

• Multiple negative tests do not completely rule out CDI in high-suspicion cases
• Consider endoscopic evaluation (pouchoscopy or colonoscopy of remaining colon) to visualize pseudomembranes
• This is particularly relevant in surgical patients with altered anatomy 5

Bottom Line

Test ostomy effluent using standard C. difficile diagnostic algorithms when patients are symptomatic. The 2019 WSES guidelines make clear that surgical patients with ostomies should be diagnosed using the same approach as general medical patients, with the modification that perirectal swabs are acceptable when stool cannot be obtained 1. The key is testing only symptomatic patients to avoid false positives from colonization.